Vitamin D, Hypercalciuria and Kidney Stones
Abstract
:1. Introduction
2. Methods
3. Vitamin D and Kidney Stones: An Old Story
3.1. Calcitriol (1,25-Dihydroxyvitamin D) and Absorptive Hypercalciuria
3.2. Why Do Calcium Stone Formers Have Higher Calcitriol Levels?
3.3. Sensitivity to Vitamin D and Kidney Stones
4. Vitamin D and Kidney Stones: Lessons from Animal Models
5. Vitamin D Serum Levels and Vitamin D Prescription: A Link with Kidney Stones?
6. Observational Studies
7. Interventional Studies
8. Randall’s Plaque and Calcium Stone Formation: A Link with Vitamin D Prescription?
9. Summary
Author Contribution
Conflicts of Interest
References
- Stamatelou, K.K.; Francis, M.E.; Jones, C.A.; Nyberg, L.M.; Curhan, G.C. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003, 63, 1817–1823. [Google Scholar] [CrossRef] [PubMed]
- Ziemba, J.B.; Matlaga, B.R. Epidemiology and economics of nephrolithiasis. Investig. Clin. Urol. 2017, 58, 299–306. [Google Scholar] [CrossRef] [PubMed]
- Borghi, L.; Schianchi, T.; Meschi, T.; Guerra, A.; Allegri, F.; Maggiore, U.; Novarini, A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N. Engl. J. Med. 2002, 346, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Daudon, M.; Doré, J.-C.; Jungers, P.; Lacour, B. Changes in stone composition according to age and gender of patients: A multivariate epidemiological approach. Urol. Res. 2004, 32, 241–247. [Google Scholar] [CrossRef] [PubMed]
- Singh, P.; Enders, F.T.; Vaughan, L.E.; Bergstralh, E.J.; Knoedler, J.J.; Krambeck, A.E.; Lieske, J.C.; Rule, A.D. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community. Mayo Clin. Proc. 2015, 90, 1356–1365. [Google Scholar] [CrossRef] [PubMed]
- Letavernier, E.; Vandermeersch, S.; Traxer, O.; Tligui, M.; Baud, L.; Ronco, P.; Haymann, J.-P.; Daudon, M. Demographics and characterization of 10,282 Randall plaque-related kidney stones: A new epidemic? Medicine 2015, 94, e566. [Google Scholar] [CrossRef] [PubMed]
- Randall, A. The origin and growth of renal calculi. Ann. Surg. 1937, 105, 1009–1027. [Google Scholar] [CrossRef] [PubMed]
- Evan, A.P.; Lingeman, J.E.; Coe, F.L.; Parks, J.H.; Bledsoe, S.B.; Shao, Y.; Sommer, A.J.; Paterson, R.F.; Kuo, R.L.; Grynpas, M. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J. Clin. Investig. 2003, 111, 607–616. [Google Scholar] [CrossRef] [PubMed]
- Kuo, R.L.; Lingeman, J.E.; Evan, A.P.; Paterson, R.F.; Parks, J.H.; Bledsoe, S.B.; Munch, L.C.; Coe, F.L. Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int. 2003, 64, 2150–2154. [Google Scholar] [CrossRef] [PubMed]
- Letavernier, E.; Bazin, D.; Daudon, M. Randall’s plaque and kidney stones: Recent advances and future challenges. C. R. Chim. 2016, 19, 1456–1460. [Google Scholar] [CrossRef]
- Verrier, C.; Bazin, D.; Huguet, L.; Stéphan, O.; Gloter, A.; Verpont, M.-C.; Frochot, V.; Haymann, J.-P.; Brocheriou, I.; Traxer, O.; et al. Topography, Composition and Structure of Incipient Randall Plaque at the Nanoscale Level. J. Urol. 2016, 196, 1566–1574. [Google Scholar] [CrossRef] [PubMed]
- Jackson, R.D.; LaCroix, A.Z.; Gass, M.; Wallace, R.B.; Robbins, J.; Lewis, C.E.; Bassford, T.; Beresford, S.A.A.; Black, H.R.; Blanchette, P.; et al. Women’s Health Initiative Investigators Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354, 669–683. [Google Scholar] [CrossRef] [PubMed]
- Lappe, J.; Watson, P.; Travers-Gustafson, D.; Recker, R.; Garland, C.; Gorham, E.; Baggerly, K.; McDonnell, S.L. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA 2017, 317, 1234–1243. [Google Scholar] [CrossRef] [PubMed]
- Malihi, Z.; Wu, Z.; Stewart, A.W.; Lawes, C.M.; Scragg, R. Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2016, 104, 1039–1051. [Google Scholar] [CrossRef] [PubMed]
- Wang, H.; Man, L.; Li, G.; Huang, G.; Liu, N. Association between serum vitamin D levels and the risk of kidney stone: Evidence from a meta-analysis. Nutr. J. 2016, 15, 32. [Google Scholar] [CrossRef] [PubMed]
- Hu, H.; Zhang, J.; Lu, Y.; Zhang, Z.; Qin, B.; Gao, H.; Wang, Y.; Zhu, J.; Wang, Q.; Zhu, Y.; et al. Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis. Nutrients 2017, 9, 301. [Google Scholar] [CrossRef] [PubMed]
- Edwards, N.A.; Hodgkinson, A. Metabolic studies in patients with idiopathic hypercalciuria. Clin. Sci. 1965, 29, 143–157. [Google Scholar] [PubMed]
- Pak, C.Y.; East, D.A.; Sanzenbacher, L.J.; Delea, C.S.; Bartter, F.C. Gastrointestinal calcium absorption in nephrolithiasis. J. Clin. Endocrinol. Metab. 1972, 35, 261–270. [Google Scholar] [CrossRef] [PubMed]
- Fleet, J.C. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol. Cell. Endocrinol. 2017, 453, 36–45. [Google Scholar] [CrossRef] [PubMed]
- Hoenderop, J.G.J.; Nilius, B.; Bindels, R.J.M. Calcium absorption across epithelia. Physiol. Rev. 2005, 85, 373–422. [Google Scholar] [CrossRef] [PubMed]
- Gkika, D.; Hsu, Y.-J.; van der Kemp, A.W.; Christakos, S.; Bindels, R.J.; Hoenderop, J.G. Critical role of the epithelial Ca2+ channel TRPV5 in active Ca2+ reabsorption as revealed by TRPV5/calbindin-D28K knockout mice. J. Am. Soc. Nephrol. JASN 2006, 17, 3020–3027. [Google Scholar] [CrossRef] [PubMed]
- Wilz, D.R.; Gray, R.W.; Dominguez, J.H.; Lemann, J. Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans. Am. J. Clin. Nutr. 1979, 32, 2052–2060. [Google Scholar] [CrossRef] [PubMed]
- Broadus, A.E.; Horst, R.L.; Lang, R.; Littledike, E.T.; Rasmussen, H. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N. Engl. J. Med. 1980, 302, 421–426. [Google Scholar] [CrossRef] [PubMed]
- Zerwekh, J.E.; Pak, C.Y.; Kaplan, R.A.; McGuire, J.L.; Upchurch, K.; Breslau, N.; Johnson, R. Pathogenetic role of 1α,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: Different response to prednisolone therapy. J. Clin. Endocrinol. Metab. 1980, 51, 381–386. [Google Scholar] [CrossRef] [PubMed]
- Gray, R.W.; Wilz, D.R.; Caldas, A.E.; Lemann, J. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: Studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1977, 45, 299–306. [Google Scholar] [CrossRef] [PubMed]
- Kaplan, R.A.; Haussler, M.R.; Deftos, L.J.; Bone, H.; Pak, C.Y. The role of 1α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Investig. 1977, 59, 756–760. [Google Scholar] [CrossRef] [PubMed]
- Shen, F.H.; Baylink, D.J.; Nielsen, R.L.; Sherrard, D.J.; Ivey, J.L.; Haussler, M.R. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J. Lab. Clin. Med. 1977, 90, 955–962. [Google Scholar] [PubMed]
- Shakhssalim, N.; Gilani, K.R.; Parvin, M.; Torbati, P.M.; Kashi, A.H.; Azadvari, M.; Golestan, B.; Basiri, A. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol. Res. 2011, 39, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Giannini, S.; Nobile, M.; Castrignano, R.; Pati, T.; Tasca, A.; Villi, G.; Pellegrini, F.; D’Angelo, A. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin. Sci. Lond. Engl. 1993, 84, 51–54. [Google Scholar] [CrossRef]
- Jarrar, K.; Amasheh, R.A.; Graef, V.; Weidner, W. Relationship between 1,25-dihydroxyvitamin-D, calcium and uric acid in urinary stone formers. Urol. Int. 1996, 56, 16–20. [Google Scholar] [CrossRef] [PubMed]
- Breslau, N.A.; Preminger, G.M.; Adams, B.V.; Otey, J.; Pak, C.Y. Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 1992, 75, 1446–1452. [Google Scholar] [CrossRef] [PubMed]
- Schlingmann, K.P.; Ruminska, J.; Kaufmann, M.; Dursun, I.; Patti, M.; Kranz, B.; Pronicka, E.; Ciara, E.; Akcay, T.; Bulus, D.; et al. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. J. Am. Soc. Nephrol. JASN 2016, 27, 604–614. [Google Scholar] [CrossRef] [PubMed]
- Hess, B.; Ackermann, D.; Essig, M.; Takkinen, R.; Jaeger, P. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: Role of protein intake. J. Clin. Endocrinol. Metab. 1995, 80, 1916–1921. [Google Scholar] [CrossRef] [PubMed]
- Schlingmann, K.P.; Kaufmann, M.; Weber, S.; Irwin, A.; Goos, C.; John, U.; Misselwitz, J.; Klaus, G.; Kuwertz-Bröking, E.; Fehrenbach, H.; et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 2011, 365, 410–421. [Google Scholar] [CrossRef] [PubMed]
- Ketha, H.; Singh, R.J.; Grebe, S.K.; Bergstralh, E.J.; Rule, A.D.; Lieske, J.C.; Kumar, R. Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers. PLoS ONE 2015, 10, e0137350. [Google Scholar] [CrossRef] [PubMed]
- Sayers, J.; Hynes, A.; Rice, S.; Hogg, P.; Sayer, J. Searching for CYP24A1 mutations in cohorts of patients with calcium nephrolithiasis. OA Nephrol. 2013, 1, 1–6. [Google Scholar] [CrossRef]
- Scott, P.; Ouimet, D.; Valiquette, L.; Guay, G.; Proulx, Y.; Trouvé, M.L.; Gagnon, B.; Bonnardeaux, A. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J. Am. Soc. Nephrol. JASN 1999, 10, 1007–1013. [Google Scholar] [PubMed]
- Seo, I.Y.; Kang, I.-H.; Chae, S.-C.; Park, S.C.; Lee, Y.-J.; Yang, Y.S.; Ryu, S.B.; Rim, J.S. Vitamin D receptor gene Alw I, Fok I, Apa I, and Taq I polymorphisms in patients with urinary stone. Urology 2010, 75, 923–927. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Chen, M.; Li, M.; Ma, H.; Tong, S.; Lei, Y.; Qi, L. Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: An updated meta-analysis based on 20 case-control studies. Urolithiasis 2014, 42, 45–52. [Google Scholar] [CrossRef] [PubMed]
- Ozkaya, O.; Söylemezoğlu, O.; Misirlioğlu, M.; Gönen, S.; Buyan, N.; Hasanoğlu, E. Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur. Urol. 2003, 44, 150–154. [Google Scholar] [CrossRef]
- Zerwekh, J.E.; Hughes, M.R.; Reed, B.Y.; Breslau, N.A.; Heller, H.J.; Lemke, M.; Nasonkin, I.; Pak, C.Y. Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 1995, 80, 2960–2965. [Google Scholar] [CrossRef] [PubMed]
- Favus, M.J.; Karnauskas, A.J.; Parks, J.H.; Coe, F.L. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 2004, 89, 4937–4943. [Google Scholar] [CrossRef] [PubMed]
- Zerwekh, J.E.; Reed, B.Y.; Heller, H.J.; González, G.B.; Haussler, M.R.; Pak, C.Y. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner. Electrolyte Metab. 1998, 24, 307–313. [Google Scholar] [CrossRef] [PubMed]
- Renkema, K.Y.; Alexander, R.T.; Bindels, R.J.; Hoenderop, J.G. Calcium and phosphate homeostasis: Concerted interplay of new regulators. Ann. Med. 2008, 40, 82–91. [Google Scholar] [CrossRef] [PubMed]
- Kido, S.; Kaneko, I.; Tatsumi, S.; Segawa, H.; Miyamoto, K. Vitamin D and type II sodium-dependent phosphate cotransporters. Contrib. Nephrol. 2013, 180, 86–97. [Google Scholar] [CrossRef] [PubMed]
- Bushinsky, D.A.; Favus, M.J. Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport. J. Clin. Investig. 1988, 82, 1585–1591. [Google Scholar] [CrossRef] [PubMed]
- Bushinsky, D.A.; Grynpas, M.D.; Nilsson, E.L.; Nakagawa, Y.; Coe, F.L. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995, 48, 1705–1713. [Google Scholar] [CrossRef] [PubMed]
- Frick, K.K.; Krieger, N.S.; Bushinsky, D.A. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat. Curr. Opin. Nephrol. Hypertens. 2015, 24, 336–344. [Google Scholar] [CrossRef] [PubMed]
- Krieger, N.S.; Stathopoulos, V.M.; Bushinsky, D.A. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am. J. Physiol. 1996, 271, C130–C135. [Google Scholar] [CrossRef] [PubMed]
- Li, X.Q.; Tembe, V.; Horwitz, G.M.; Bushinsky, D.A.; Favus, M.J. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J. Clin. Investig. 1993, 91, 661–667. [Google Scholar] [CrossRef] [PubMed]
- Tsuruoka, S.; Bushinsky, D.A.; Schwartz, G.J. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int. 1997, 51, 1540–1547. [Google Scholar] [CrossRef] [PubMed]
- Maierhofer, W.J.; Gray, R.W.; Cheung, H.S.; Lemann, J. Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int. 1983, 24, 555–560. [Google Scholar] [CrossRef] [PubMed]
- Lieben, L.; Masuyama, R.; Torrekens, S.; Van Looveren, R.; Schrooten, J.; Baatsen, P.; Lafage-Proust, M.-H.; Dresselaers, T.; Feng, J.Q.; Bonewald, L.F.; et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Investig. 2012, 122, 1803–1815. [Google Scholar] [CrossRef] [PubMed]
- Letavernier, E.; Verrier, C.; Goussard, F.; Perez, J.; Huguet, L.; Haymann, J.-P.; Baud, L.; Bazin, D.; Daudon, M. Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease. Kidney Int. 2016, 90, 809–817. [Google Scholar] [CrossRef] [PubMed]
- Taylor, E.N.; Curhan, G.C. Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones. J. Urol. 2013, 190, 1255–1259. [Google Scholar] [CrossRef] [PubMed]
- Berlin, T.; Björkhem, I.; Collste, L.; Holmberg, I.; Wijkström, H. Relation between hypercalciuria and vitamin D3-status in patients with urolithiasis. Scand. J. Urol. Nephrol. 1982, 16, 269–273. [Google Scholar] [CrossRef] [PubMed]
- Fallahzadeh, M.H.; Zare, J.; Al-Hashemi, G.H.; Derakhshan, A.; Basiratnia, M.; Arasteh, M.M.; Fallahzadeh, M.A.; Fallahzadeh, M.K. Elevated serum levels of Vitamin D in infants with urolithiasis. Iran. J. Kidney Dis. 2012, 6, 186–191. [Google Scholar] [PubMed]
- Tang, J.; McFann, K.K.; Chonchol, M.B. Association between serum 25-hydroxyvitamin D and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988–1994. Nephrol. Dial. Transplant. 2012, 27, 4385–4389. [Google Scholar] [CrossRef] [PubMed]
- Eisner, B.H.; Thavaseelan, S.; Sheth, S.; Haleblian, G.; Pareek, G. Relationship between serum vitamin D and 24-h urine calcium in patients with nephrolithiasis. Urology 2012, 80, 1007–1010. [Google Scholar] [CrossRef] [PubMed]
- Ferraro, P.M.; Taylor, E.N.; Gambaro, G.; Curhan, G.C. Vitamin D Intake and the Risk of Incident Kidney Stones. J. Urol. 2017, 197, 405–410. [Google Scholar] [CrossRef] [PubMed]
- Taylor, E.N.; Hoofnagle, A.N.; Curhan, G.C. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin. J. Am. Soc. Nephrol. CJASN 2015, 10, 667–675. [Google Scholar] [CrossRef] [PubMed]
- Netelenbos, J.C.; Jongen, M.J.; van der Vijgh, W.J.; Lips, P.; van Ginkel, F.C. Vitamin D status in urinary calcium stone formation. Arch. Intern. Med. 1985, 145, 681–684. [Google Scholar] [CrossRef] [PubMed]
- Moses, R.; Pais, V.M.; Ursiny, M.; Prien, E.L.; Miller, N.; Eisner, B.H. Changes in stone composition over two decades: Evaluation of over 10,000 stone analyses. Urolithiasis 2015, 43, 135–139. [Google Scholar] [CrossRef] [PubMed]
- Wu, W.; Yang, B.; Ou, L.; Liang, Y.; Wan, S.; Li, S.; Zeng, G. Urinary stone analysis on 12,846 patients: A report from a single center in China. Urolithiasis 2014, 42, 39–43. [Google Scholar] [CrossRef] [PubMed]
- Daudon, M.; Letavernier, E.; Frochot, V.; Haymann, J.-P.; Bazin, D.; Jungers, P. Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals. C. R. Chim. 2016, 19, 1504–1513. [Google Scholar] [CrossRef]
- Gallagher, J.C.; Smith, L.M.; Yalamanchili, V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause 2014, 21, 1173–1180. [Google Scholar] [CrossRef] [PubMed]
- Curhan, G.C.; Willett, W.C.; Speizer, F.E.; Spiegelman, D.; Stampfer, M.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann. Intern. Med. 1997, 126, 497–504. [Google Scholar] [CrossRef] [PubMed]
- Avenell, A.; Mak, J.C.S.; O’Connell, D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst. Rev. 2014, CD000227. [Google Scholar] [CrossRef] [PubMed]
- Bjelakovic, G.; Gluud, L.L.; Nikolova, D.; Whitfield, K.; Wetterslev, J.; Simonetti, R.G.; Bjelakovic, M.; Gluud, C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2014, CD007470. [Google Scholar] [CrossRef] [PubMed]
- Leaf, D.E.; Korets, R.; Taylor, E.N.; Tang, J.; Asplin, J.R.; Goldfarb, D.S.; Gupta, M.; Curhan, G.C. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin. J. Am. Soc. Nephrol. CJASN 2012, 7, 829–834. [Google Scholar] [CrossRef] [PubMed]
- Johri, N.; Jaeger, P.; Ferraro, P.M.; Shavit, L.; Nair, D.; Robertson, W.G.; Gambaro, G.; Unwin, R.J. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? Urolithiasis 2017, 45, 535–543. [Google Scholar] [CrossRef] [PubMed]
- Rosenow, E.J. Renal calculi: Study of papillary calcification. J. Urol. 1940, 44, 19–28. [Google Scholar] [CrossRef]
- Vermooten, V. The incidence and significance of the deposition of calcium plaques in the renal papilla as observed in the Caucasian and Bantu population in South Africa. J. Urol. 1941, 46, 193–200. [Google Scholar] [CrossRef]
- Low, R.K.; Stoller, M.L. Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J. Urol. 1997, 158, 2062–2064. [Google Scholar] [CrossRef]
- Kim, S.C.; Coe, F.L.; Tinmouth, W.W.; Kuo, R.L.; Paterson, R.F.; Parks, J.H.; Munch, L.C.; Evan, A.P.; Lingeman, J.E. Stone formation is proportional to papillary surface coverage by Randall’s plaque. J. Urol. 2005, 173, 117–119. [Google Scholar] [CrossRef] [PubMed]
- Matlaga, B.R.; Williams, J.C.; Kim, S.C.; Kuo, R.L.; Evan, A.P.; Bledsoe, S.B.; Coe, F.L.; Worcester, E.M.; Munch, L.C.; Lingeman, J.E. Endoscopic evidence of calculus attachment to Randall’s plaque. J. Urol. 2006, 175, 1720–1724. [Google Scholar] [CrossRef]
- Daudon, M.; Bazin, D.; Letavernier, E. Randall’s plaque as the origin of calcium oxalate kidney stones. Urolithiasis 2015, 43 (Suppl. 1), 5–11. [Google Scholar] [CrossRef] [PubMed]
- Bolland, M.J.; Grey, A.; Gamble, G.D.; Reid, I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014, 2, 307–320. [Google Scholar] [CrossRef]
- Reid, I.R.; Bolland, M.J.; Grey, A. Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis. Lancet Lond. Engl. 2014, 383, 146–155. [Google Scholar] [CrossRef]
- Autier, P.; Boniol, M.; Pizot, C.; Mullie, P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol. 2014, 2, 76–89. [Google Scholar] [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Letavernier, E.; Daudon, M. Vitamin D, Hypercalciuria and Kidney Stones. Nutrients 2018, 10, 366. https://doi.org/10.3390/nu10030366
Letavernier E, Daudon M. Vitamin D, Hypercalciuria and Kidney Stones. Nutrients. 2018; 10(3):366. https://doi.org/10.3390/nu10030366
Chicago/Turabian StyleLetavernier, Emmanuel, and Michel Daudon. 2018. "Vitamin D, Hypercalciuria and Kidney Stones" Nutrients 10, no. 3: 366. https://doi.org/10.3390/nu10030366
APA StyleLetavernier, E., & Daudon, M. (2018). Vitamin D, Hypercalciuria and Kidney Stones. Nutrients, 10(3), 366. https://doi.org/10.3390/nu10030366